A method for determining the total content of the oxypurines xanthine and hypoxanthine in urine is described which is technically simplified and has greater specificity than existing methods. This method is highly specific, reproducible, and accurate. It also allows an estimation of the present xanthine and hypoxanthine in the urine without performing any additional measurements.When applied to plasma, special concentrating proceduresare required and the method is therefore lessprecise.
It has also provided a new approach to the treatment of gout through its inhibition of uric acid production.
The oxypurines xanthine and hypoxanthine appear in increased quantities in the urine and serum as a consequence of administration of allopurinol (2) . 
Procedure Total Oxypurine Concentration in Urine
Total oxypurines = total uric acid -preformed uric acid. Urine is collected with 3 ml. toluene as a preservative and stored at room temperature to prevent the precipitation of any uric acid or oxypurine.
Tile usual period of urine collection is 24 hr. After appropriate dilution with water (usually iii the range of 1 :50 to 1 :200) the sample can be stored in a tightly sealed container at 5#{176} for at least 21 days without significant cilange in content of uric acid or oxypurines.
Preformed Uric Acid
This is determined by the method of Liddle et al. (7). Duplicate assay cuvets each contain 2.0 ml. of 0.1 NI glycine pH 9.4 and 1.0 ml. of urine diluted sufficiently to give an absorbance at 292 urn of approximately 0. 
Total Oxypurines
A of uric acid derived from oxvpunine = A total uric acid minus A preformed uric acid.
Calculations uM total oxypunilse A uric acid derived from oxypurine X 3.01 ml. X dilution of urine Ml. of urine 12.5 A/pM/mI.
Percent Xanthine and Hypoxanthine
The increase in absorbance at 292 nm accompanying the oxidation of 1. 
Reproducibility
The reproducibility for uric acid determination by the unease method has previously been determined (8). The reproducibility for total oxypunine determination in the urine and plasma is shown graphically in Fig. 3 
